Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ross

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1995
Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cellsP F Lenehan, P L Gutiérrez, J L Wagner, et al.
Leukemia|June 23, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and functionA Suvannasankha, H Minderman, K L O'Loughlin, et al.
Cancer Research|July 26, 2000
Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug effluxE L Volk, K Rohde, M Rhee, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
A multidrug resistance transporter from human MCF-7 breast cancer cellsL A Doyle, W Yang, L V Abruzzo, et al.
Blood Cells, Molecules & Diseases|January 11, 2002
PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cellsM Simons-Evelyn, K Bailey-Dell, J A Toretsky, et al.
Cancer Research|June 1, 1981
Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cellsS A Akman, D D Ross, H Rosen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 5, 1997
Hospice and palliative care education in medical school: a module on the role of the physician in end-of-life careD D Ross, A O'Mara, N Pickens, et al.
Experimental Hematology|August 1, 1983
Variation amongst K562 cell culturesI W Dimery, D D Ross, J R Testa, et al.
British Journal of Cancer|January 1, 1995
Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cellsL A Doyle, D D Ross, R Sridhara, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1983
Detection in human serum by radioimmunoassay of histidyl-proline diketopiperazine, a metabolite of thyrotropin-releasing hormoneY Takahara, F Battaini, D D Ross, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 1, 1995
Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cellsP F Lenehan, P L Gutiérrez, J L Wagner, et al.
Leukemia|June 23, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and functionA Suvannasankha, H Minderman, K L O'Loughlin, et al.
Cancer Research|July 26, 2000
Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug effluxE L Volk, K Rohde, M Rhee, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
A multidrug resistance transporter from human MCF-7 breast cancer cellsL A Doyle, W Yang, L V Abruzzo, et al.
Blood Cells, Molecules & Diseases|January 11, 2002
PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cellsM Simons-Evelyn, K Bailey-Dell, J A Toretsky, et al.
Cancer Research|June 1, 1981
Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cellsS A Akman, D D Ross, H Rosen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 5, 1997
Hospice and palliative care education in medical school: a module on the role of the physician in end-of-life careD D Ross, A O'Mara, N Pickens, et al.
Experimental Hematology|August 1, 1983
Variation amongst K562 cell culturesI W Dimery, D D Ross, J R Testa, et al.
British Journal of Cancer|January 1, 1995
Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cellsL A Doyle, D D Ross, R Sridhara, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1983
Detection in human serum by radioimmunoassay of histidyl-proline diketopiperazine, a metabolite of thyrotropin-releasing hormoneY Takahara, F Battaini, D D Ross, et al.
Pageof 7